182 related articles for article (PubMed ID: 21709583)
1. Chronic β-adrenoceptor antagonist treatment controls cardiovascular remodeling in heart failure in the aging spontaneously hypertensive rat.
Chan V; Fenning A; Hoey A; Brown L
J Cardiovasc Pharmacol; 2011 Oct; 58(4):424-31. PubMed ID: 21709583
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin attenuates heart failure and cardiac remodelling in the ageing spontaneously hypertensive rat.
Loch D; Chan V; Hoey A; Brown L
Basic Clin Pharmacol Toxicol; 2009 Oct; 105(4):262-70. PubMed ID: 19583711
[TBL] [Abstract][Full Text] [Related]
3. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
Kobayashi M; Machida N; Mitsuishi M; Yamane Y
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling.
Rinaldi B; Donniacuo M; Sodano L; Gritti G; Martuscelli E; Orlandi A; Rafaniello C; Rossi F; Calzetta L; Capuano A; Matera MG
Br J Pharmacol; 2015 Jul; 172(14):3627-37. PubMed ID: 25825265
[TBL] [Abstract][Full Text] [Related]
5. Reduced hemodynamic load aids low-dose resveratrol in reversing cardiovascular defects in hypertensive rats.
Thandapilly SJ; Louis XL; Behbahani J; Movahed A; Yu L; Fandrich R; Zhang S; Kardami E; Anderson HD; Netticadan T
Hypertens Res; 2013 Oct; 36(10):866-72. PubMed ID: 23784505
[TBL] [Abstract][Full Text] [Related]
6. Association of histamine with hypertension-induced cardiac remodeling and reduction of hypertrophy with the histamine-2-receptor antagonist famotidine compared with the beta-blocker metoprolol.
Potnuri AG; Allakonda L; Appavoo A; Saheera S; Nair RR
Hypertens Res; 2018 Dec; 41(12):1023-1035. PubMed ID: 30310171
[TBL] [Abstract][Full Text] [Related]
7. [The effects of combined beta(1) adrenergic receptor antagonist and beta(2) adrenergic receptor agonist therapy on cardiac function and myocardial apoptosis in heart failure rats].
Li WM; Gan RT; Wang X; Wu S; Shen JX; Xiu CH
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):615-9. PubMed ID: 17961425
[TBL] [Abstract][Full Text] [Related]
8. Fluvastatin decreases cardiac fibrosis possibly through regulation of TGF-beta(1)/Smad 7 expression in the spontaneously hypertensive rats.
Zhai Y; Gao X; Wu Q; Peng L; Lin J; Zuo Z
Eur J Pharmacol; 2008 Jun; 587(1-3):196-203. PubMed ID: 18430418
[TBL] [Abstract][Full Text] [Related]
9. Effect of farnesyltransferase inhibition on cardiac remodeling in spontaneously hypertensive rats.
Li X; Han J; Li L; Wang KJ; Hu SJ
Int J Cardiol; 2013 Oct; 168(4):3340-7. PubMed ID: 23664044
[TBL] [Abstract][Full Text] [Related]
10. Improvement of left ventricular diastolic function induced by β-blockade: a comparison between nebivolol and metoprolol.
Fang Y; Nicol L; Harouki N; Monteil C; Wecker D; Debunne M; Bauer F; Lallemand F; Richard V; Thuillez C; Mulder P
J Mol Cell Cardiol; 2011 Aug; 51(2):168-76. PubMed ID: 21640121
[TBL] [Abstract][Full Text] [Related]
11. TNFalpha antagonist upregulates interleukin-6 in rats with hypertensive heart failure.
Haugen E; Täng MS; Isic A; Andersson B; Fu M
Int J Cardiol; 2008 Oct; 130(1):64-8. PubMed ID: 18280594
[TBL] [Abstract][Full Text] [Related]
12. Role of heart rate reduction in the prevention of experimental heart failure: comparison between If-channel blockade and β-receptor blockade.
Becher PM; Lindner D; Miteva K; Savvatis K; Zietsch C; Schmack B; Van Linthout S; Westermann D; Schultheiss HP; Tschöpe C
Hypertension; 2012 May; 59(5):949-57. PubMed ID: 22493071
[TBL] [Abstract][Full Text] [Related]
13. Chronic administration of genistein improves endothelial dysfunction in spontaneously hypertensive rats: involvement of eNOS, caveolin and calmodulin expression and NADPH oxidase activity.
Vera R; Sánchez M; Galisteo M; Villar IC; Jimenez R; Zarzuelo A; Pérez-Vizcaíno F; Duarte J
Clin Sci (Lond); 2007 Feb; 112(3):183-91. PubMed ID: 17007611
[TBL] [Abstract][Full Text] [Related]
14. Dilated cardiomyopathy with hypertension: prevalence and response to high-dose β1-adrenoceptor antagonist therapy.
Zheng X; Chen S; Wang J; Yang T; Chen Y
Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):945-9. PubMed ID: 19473337
[TBL] [Abstract][Full Text] [Related]
15. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C
J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
[TBL] [Abstract][Full Text] [Related]
16. Amlodipine decreases fibrosis and cardiac hypertrophy in spontaneously hypertensive rats: persistent effects after withdrawal.
Sevilla MA; Voces F; Carrón R; Guerrero EI; Ardanaz N; San Román L; Arévalo MA; Montero MJ
Life Sci; 2004 Jul; 75(7):881-91. PubMed ID: 15183079
[TBL] [Abstract][Full Text] [Related]
17. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
18. Antihypertension and anti-cardiovascular remodeling by phenylalanine in spontaneously hypertensive rats: effectiveness and mechanisms.
Zhao G; Li Z; Gu T
Chin Med J (Engl); 2001 Mar; 114(3):270-4. PubMed ID: 11780312
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats.
Iyer A; Woodruff TM; Wu MC; Stylianou C; Reid RC; Fairlie DP; Taylor SM; Brown L
J Cardiovasc Pharmacol; 2011 Nov; 58(5):479-86. PubMed ID: 21753735
[TBL] [Abstract][Full Text] [Related]
20. Exaggerated blood pressure variability superimposed on hypertension aggravates cardiac remodeling in rats via angiotensin II system-mediated chronic inflammation.
Kudo H; Kai H; Kajimoto H; Koga M; Takayama N; Mori T; Ikeda A; Yasuoka S; Anegawa T; Mifune H; Kato S; Hirooka Y; Imaizumi T
Hypertension; 2009 Oct; 54(4):832-8. PubMed ID: 19704105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
